DE3850844T2 - Orales Präparat von Buspiron und seinen Salzen. - Google Patents

Orales Präparat von Buspiron und seinen Salzen.

Info

Publication number
DE3850844T2
DE3850844T2 DE3850844T DE3850844T DE3850844T2 DE 3850844 T2 DE3850844 T2 DE 3850844T2 DE 3850844 T DE3850844 T DE 3850844T DE 3850844 T DE3850844 T DE 3850844T DE 3850844 T2 DE3850844 T2 DE 3850844T2
Authority
DE
Germany
Prior art keywords
buspirone
salts
oral preparation
bioavailability
increase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3850844T
Other languages
English (en)
Other versions
DE3850844D1 (de
Inventor
Alf Gunnar Martin Nicklasson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DE3850844D1 publication Critical patent/DE3850844D1/de
Publication of DE3850844T2 publication Critical patent/DE3850844T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
DE3850844T 1987-10-22 1988-10-17 Orales Präparat von Buspiron und seinen Salzen. Expired - Fee Related DE3850844T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8704097A SE8704097D0 (sv) 1987-10-22 1987-10-22 Oral formulation of buspirone and salts thereof

Publications (2)

Publication Number Publication Date
DE3850844D1 DE3850844D1 (de) 1994-09-01
DE3850844T2 true DE3850844T2 (de) 1994-12-08

Family

ID=20369959

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3850844T Expired - Fee Related DE3850844T2 (de) 1987-10-22 1988-10-17 Orales Präparat von Buspiron und seinen Salzen.

Country Status (21)

Country Link
EP (1) EP0313535B1 (de)
JP (1) JP2674170B2 (de)
KR (1) KR970004906B1 (de)
AT (1) ATE108997T1 (de)
AU (1) AU604585B2 (de)
CY (1) CY1814A (de)
DE (1) DE3850844T2 (de)
DK (1) DK294489D0 (de)
ES (1) ES2056955T3 (de)
FI (1) FI100303B (de)
HK (1) HK21295A (de)
HU (1) HU204998B (de)
IE (1) IE64705B1 (de)
IL (1) IL88020A (de)
NO (1) NO892512D0 (de)
NZ (1) NZ226604A (de)
PT (1) PT88820B (de)
SE (1) SE8704097D0 (de)
WO (1) WO1989003676A1 (de)
YU (1) YU47903B (de)
ZA (1) ZA887624B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208495B (en) * 1990-06-27 1993-11-29 Alkaloida Vegyeszeti Gyar Process for producing retarde pharmaceutical compositions
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
DE4341156C2 (de) * 1993-12-02 1997-11-13 Wacker Chemie Gmbh Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
DE59804823D1 (de) * 1997-09-25 2002-08-22 Bayer Ag Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
US6268368B1 (en) * 2000-03-01 2001-07-31 American Pharmaceuticals International Anionic exchange polymer complexes of buspirone
CN117257747B (zh) * 2023-11-21 2024-01-30 泊诺(天津)创新医药研究有限公司 一种盐酸丁螺环酮片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
SE353229B (de) * 1970-06-04 1973-01-29 Haessle Ab
US4182703A (en) * 1978-01-09 1980-01-08 Eastman Kodak Company Biheterocyclic ultraviolet stabilizers and their use in organic compositions
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4693895A (en) * 1984-10-26 1987-09-15 Alza Corporation Colon delivery system
US4634703A (en) * 1985-10-25 1987-01-06 Bristol-Myers Company Method for alleviation of panic disorders
US4640921A (en) * 1986-02-04 1987-02-03 Bristol-Myers Treatment of sexual dysfunction with buspirone

Also Published As

Publication number Publication date
KR970004906B1 (ko) 1997-04-08
HU204998B (en) 1992-03-30
DK294489A (da) 1989-06-15
EP0313535B1 (de) 1994-07-27
PT88820B (pt) 1993-01-29
JP2674170B2 (ja) 1997-11-12
DK294489D0 (da) 1989-06-15
FI893017A0 (fi) 1989-06-20
YU47903B (sh) 1996-05-20
IE64705B1 (en) 1995-08-23
NO892512L (no) 1989-06-16
SE8704097D0 (sv) 1987-10-22
CY1814A (en) 1995-10-20
IL88020A0 (en) 1989-06-30
FI100303B (fi) 1997-11-14
EP0313535A1 (de) 1989-04-26
FI893017A (fi) 1989-06-20
NO892512D0 (no) 1989-06-16
HU886266D0 (en) 1991-01-28
AU2623688A (en) 1989-05-23
WO1989003676A1 (en) 1989-05-05
DE3850844D1 (de) 1994-09-01
ZA887624B (en) 1989-06-28
ATE108997T1 (de) 1994-08-15
AU604585B2 (en) 1990-12-20
YU196488A (en) 1990-04-30
ES2056955T3 (es) 1994-10-16
JPH02501744A (ja) 1990-06-14
KR890701087A (ko) 1989-12-19
IL88020A (en) 1993-08-18
HUT54495A (en) 1991-03-28
HK21295A (en) 1995-02-24
NZ226604A (en) 1991-07-26
IE883177L (en) 1989-04-22

Similar Documents

Publication Publication Date Title
NO882732L (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DK333788D0 (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
NO171365C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO883506L (no) Fremgangsmaate for fremstilling av foretrede polyoksyalkylenderivater.
NO168353C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2'-aminofenyl)-benzamidderivater
DE69206495T2 (de) Matrixtablette zur verlängerten Indapamidfreisetzung nach oraler Gabe.
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
NO874955L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater.
DE3850844D1 (de) Orales Präparat von Buspiron und seinen Salzen.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO870049L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO172490C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
IT1223343B (it) Formulazioni farmaceutiche per somministrazione transdermica
NO169835C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive katecholkarboksylderivater
NO171211C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
DK116687A (da) Farmaceutisk praeparat indeholdende aenovantroneae
NO170017C (no) Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater
NO171210C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenofuran-derivater
DK152987D0 (da) Dosageform for nonimmediate release of one or more drugs
IT7903521A0 (it) Procedimento per la preparazione diforme farmaceutiche prive di sapori sgradevoli per la somministrazione orale

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee